Variable | Control Group | CAD Group | P value |
---|---|---|---|
(n = 162) | (n = 381) | ||
Age (years) | 55.41 ± 9.28 | 62.79 ± 9.52 | <0.01 |
Male, n (%) | 57(35%) | 211(55%) | < 0.01 |
Family history, n (%) | 20(12%) | 55(14%) | 0.52 |
Smoking, n (%) | 46(28%) | 186(49%) | < 0.01 |
DM, n (%) | 25(15%) | 139(36%) | < 0.01 |
HT, n (%) | 85(52%) | 291(76%) | < 0.01 |
HGB (g/L) | 135.33 ± 15.87 | 136.53 ± 15.53 | 0.42 |
Platelet (109/L) | 221.32 ± 51.31 | 211.14 ± 53.40 | 0.04 |
Leukocyte (109/L) | 6.07(4.99–7.13) | 6.60(5.60–7.70) | < 0.01 |
Neutrophil (109/L) | 3.42(2.95–4.41) | 4.24(3.40–5.10) | < 0.01 |
Monocyte (108/L) | 3.02(2.51–3.62) | 3.92(3.22–4.94) | < 0.01 |
Lymphocyte (109/L) | 1.95(1.49–2.29) | 1.70(1.36–2.19) | < 0.01 |
FBG (mmol/L) | 5.35(4.93–5.88) | 6.22(5.35–7.76) | < 0.01 |
TC (mmol/L) | 4.84 ± 1.10 | 4.99 ± 1.13 | 0.15 |
TG (mmol/L) | 1.51(1.06–2.23) | 1.51(1.13–2.30) | 0.36 |
LDL (mmol/L) | 2.65(2.12–3.25) | 2.73(2.23–3.43) | 0.29 |
HDL (mmol/L) | 1.16(0.94–1.39) | 1.07(0.92–1.30) | 0.03 |
SCr (μmol/L) | 71.34(59.27–83.51) | 75.96(64.82–89.80) | < 0.01 |
UA (μmol/L) | 334.12 ± 93.41 | 335.56 ± 91.61 | 0.87 |
NLR | 1.87(1.42–2.36) | 2.47(1.86–3.34) | < 0.01 |
MLR | 0.16(0.13–0.21) | 0.23 (0.17–0.30) | < 0.01 |
Prior Medications | |||
Aspirin, n (%) | 133(82%) | 320(84%) | 0.59 |
Beta-blocker, n (%) | 61(38%) | 170(45%) | 0.13 |
ACEI/ARB, n (%) | 70(43%) | 194(51%) | 0.10 |
Stain, n (%) | 129(80%) | 317(83%) | 0.32 |